NIH SBIR — Receipt (First Post-Reauthorization
Supports United States. small businesses moving vision innovation from feasibility to development.
The NIH Small Business Innovation Research (SBIR) program funds commercially oriented biomedical and health technology R&D by US small businesses across the full NIH portfolio and partner agencies CDC and FDA. The program was reauthorized on April 13, 2026 following a lapse; as of May 2026, NIH has no active SBIR Notice of Funding Opportunity. The next standard receipt date is September 5, 2026, a…
Small business commercialization of biomedical and health technology innovations across all NIH Institutes and Centers, with Phase I feasibility awards up to approximately $314,000 and Phase II awards up to approximately $2.1 million.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see the timeline
Guides for this application
All guides →SBIR/STTR Grants for Deeptech Startups
A practical guide to SBIR and STTR grants for deeptech startups, including agency fit, Phase I and II logic, eligibility, budgets, and review criteria.
DocumentsNIH Biosketch Guide: Format, SciENcv Steps, and Examples
Learn what an NIH biosketch is, how the format works, what to prepare for SciENcv, and how startup teams should avoid common biosketch mistakes.
Write proposalHow to Write a Specific Aims Page
Learn how to write a specific aims page for NIH, SBIR-adjacent, and translational R&D grants, with structure, reviewer logic, examples, and common mistakes.
Where to applyGrants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
More from NIH
All grants from this funder →Development and Testing of a Multi-use Frameworks Playbook for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI)
🇺🇸NIH · United States
Funds the design and early validation of frameworks — guidelines, protocols and standard procedures — for building and deploying multimodal medical AI reliably.
Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Clinical Centers
🇺🇸NIH · United States
Funds a clinical centre inside a consortium testing how to use anti-obesity medication in children without harming their growth or mental health.
Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Research Coordinating Center
🇺🇸NIH · United States
Funds the single centre that runs statistics, data and coordination for the consortium testing anti-obesity medication in children.
Addressing Methodological Challenges with Clinical Trials of Rapid-Acting Psychotropic Interventional Drugs (RAPIDs)
🇺🇸NIH · United States
Funds work on the methodological problems that make trials of rapid-acting psychotropic drugs hard to interpret, and on sustaining the treatment afterwards.
Assay Validation of High Quality Markers for Clinical Studies in Cancer
🇺🇸NIH · United States
Funds two years of analytical validation then three of clinical validation for a cancer biomarker assay that already works on human samples.
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3)
🇺🇸NIH · United States
Funds the clinical validation of a cancer biomarker assay whose analytical performance has already been proven.
Similar grants
Browse the directory →
NCI SBIR/STTR Omnibus (Next Receipt 5)
🇺🇸NCI · United States
Supports small businesses developing cancer technologies through national NIH collaboration pathways.
NIH CRP Commercialization Readiness Pilot
🇺🇸NIH SEED · United States
Offers late stage commercialization readiness support through NIH CRP for small firms advancing biomedical health solutions.
NIH SBIR Phase II
🇺🇸NIH SEED · United States
Supports United States biomedical small businesses advancing successful feasibility work into scale-up development.
NIDA SBIR/STTR
🇺🇸NIDA · United States
Supports United States. small businesses advancing drug abuse intervention and treatment technologies.
NEI SBIR Phase II — R&D
🇺🇸NEI · United States
Supports United States. small businesses scaling vision concepts into full development pathways.
NSF SBIR/STTR Fast-Track Pilot
🇺🇸NSF · United States
Supports United States deep-tech startups through a combined early and continuation development route.